Neutralizing human monoclonal antibody against H5N1 influenza HA selected from a Fab-phage display library
Open Access
- 28 October 2008
- journal article
- Published by Springer Nature in Virology Journal
- Vol. 5 (1) , 130
- https://doi.org/10.1186/1743-422x-5-130
Abstract
Identification of neutralizing antibodies with specificity away from the traditional mutation prone antigenic regions, against the conserved regions of hemagglutinin from H5N1 influenza virus has the potential to provide a therapeutic option which can be developed ahead of time in preparation for a possible pandemic due to H5N1 viruses. In this study, we used a combination of panning strategies against the hemagglutinin (HA) of several antigenic distinct H5N1 isolates to bias selection of Fab-phage from a naïve human library away from the antigenic regions of HA, toward the more conserved portions of the protein. All of the identified Fab clones which showed binding to multiple antigenically distinct HA were converted to fully human IgG, and tested for their ability to neutralize the uptake of H5N1-virus like particles (VLP) into MDCK cells. Five of the antibodies which showed binding to the relatively conserved HA2 subunit of HA, exhibited neutralization of H5N1-VLP uptake in a dose dependant manner. The inhibitory effects of these five antibodies were similar to those observed with a previously described neutralizing antibody specific for the 140s antigenic loop present within HA1 and highlight the exciting possibility that these antibodies may be efficacious against multiple H5N1 strains.Keywords
This publication has 37 references indexed in Scilit:
- Epitope characterization of the protective monoclonal antibody VN04-2 shows broadly neutralizing activity against highly pathogenic H5N1Virology Journal, 2008
- The Influenza Virus Resource at the National Center for Biotechnology InformationJournal of Virology, 2008
- Epitope Mapping of the Hemagglutinin Molecule of a Highly Pathogenic H5N1 Influenza Virus by Using Monoclonal AntibodiesJournal of Virology, 2007
- Prophylactic and Therapeutic Efficacy of Human Monoclonal Antibodies against H5N1 InfluenzaPLoS Medicine, 2007
- Emergence of drug resistance: implications for antiviral control of pandemic influenzaProceedings Of The Royal Society B-Biological Sciences, 2007
- Efficacy of Oseltamivir Therapy in Ferrets Inoculated with Different Clades of H5N1 Influenza VirusAntimicrobial Agents and Chemotherapy, 2007
- Emerging Respiratory Viruses: Challenges and Vaccine StrategiesClinical Microbiology Reviews, 2006
- Immunogenicity and anti-Burkholderia pseudomallei activity in Balb/c mice immunized with plasmid DNA encoding flagellinVaccine, 2006
- Inhibition of fusion activity of influenza A haemagglutinin mediated by HA2-specific monoclonal antibodiesArchiv für die gesamte Virusforschung, 2003
- Isolation of cross-reactive, subtype-specific monoclonal antibodies against influenza virus HA1 and HA2 hemagglutinin subunitsArchiv für die gesamte Virusforschung, 1987